Usana Health Sciences Inc. (USNA)

AI-Powered SEC Filing Analysis

Current Report Filed: 2026-01-08

Key Insights

  • USANA Health Sciences announced a leadership transition, with co-founder Kevin Guest reassuming the role of CEO after Jim Brown stepped down.
  • The compensation arrangements for the departing CEO and incoming CEO are still being determined by the Compensation Committee and will be disclosed in a future filing.
  • Kevin Guest has a long history with USANA, having held various executive roles since joining the company in 2003 and previously serving as CEO from 2015-2016.
Filing tone (AI): Neutral
View Original Filing →

Filings on this page are at least 90 days old. In the app, any new Usana Health Sciences Inc. filing is analysed the moment you open it.

Download on theApp Store Get it onGoogle Play

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.